CORC

在结果中检索

CORC

浏览/检索结果: 共23条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Discovery and Structural Optimization of N5-Substituted 6,7-Dioxo-6,7-dihydropteridines as Potent and Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors against L858R/T790M Resistance Mutation 期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 卷号: 59, 期号: 15, 页码: 7111-7124
作者:  Hao, Yongjia;  Wang, Xia;  Zhang, Tao;  Sun, Deheng;  Tong, Yi
收藏  |  浏览/下载：32/0  |  提交时间：2019/01/08
Second-line afatinib vs erlotinib for patients with squamous cell carcinoma of the lung in LUX-Lung 8: analysis of tumor and serum biomarkers 期刊论文
ANNALS OF ONCOLOGY, 2016, 卷号: 27
作者:  Lee, K. H.;  Soria, J-C.;  Felip, E.;  Cobo, M.;  Lu, S.
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
Efficacy and safety of bevacizumab plus erlotinib versus bevacizumab or erlotinib alone in the treatment of non-small-cell lung cancer: a systematic review and meta-analysis 期刊论文
BMJ OPEN, 2016, 卷号: 6, 期号: 6
作者:  Zhang, Shu;  Mao, Xiao-dong;  Wang, Hai-tao;  Cai, Feng;  Xu, Jing
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05
Chronopharmacokinetics of Erlotinib and Circadian Rhythms of Related Metabolic Enzymes in Lewis Tumor-Bearing Mice 期刊论文
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2016, 卷号: 41, 期号: 5
作者:  Liu, Jiao;  Wang, Chun-Yan;  Ji, Song-Gang;  Xu, Xia;  Wang, Pei-Pei
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05
PS01.80: Genome-Wide Screen of DNA Methylation Changes Reveals GABBR2 as a Novel Potential Target for EGFR 19 Deletion Adenocarcinoma with Erlotinib: Topic: Medical Oncology. 期刊论文
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2016, 卷号: 11, 期号: 11S
作者:  Lu Shun;  Niu Xiaomin;  Liu Fatao;  Zhou Yi;  Zhou Zhen
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05
Erlotinib for advanced hepatocellular carcinoma A systematic review of phase II/III clinical trials 期刊论文
SAUDI MEDICAL JOURNAL, 2016, 卷号: 37, 页码: 1184-1190
作者:  Zhang, Jing;  Zong, Yuan;  Xu, Gang-Zhu;  Xing, Ke
收藏  |  浏览/下载：3/0  |  提交时间：2019/11/26
Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy 期刊论文
Journal of Controlled Release, 2016, 卷号: 229, 页码: 80-92
作者:  He, Yongju;  Su, Zhigui;  Xue, Lingjing;  Xu, Hui*;  Zhang, Can*
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/03
Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment 期刊论文
CANCER LETTERS, 2016, 卷号: 380, 期号: [db:dc_citation_issue], 页码: 494-504
作者:  Shi, Puyu;  Oh, You Take;  Zhang, Guojing;  Yao, Weilong;  Yue, Ping
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/02
Bim  EGFR  Resistance  AZD9291  Met  Erlotinib  
Erlotinib Analogue-substituted Zinc(II) Phthalocyanines for Small Molecular Target-based Photodynamic Cancer Therapy 会议论文
作者:  Chen, Juanjuan;  Ye, Huannian;  Zhang, Mingjun;  Li, Jinyu;  Liu, Jianyong
收藏  |  浏览/下载：9/0  |  提交时间：2019/11/21
Efficacy and safety of bevacizumab plus erlotinib versus bevacizumab or erlotinib alone in the treatment of non-small-cell lung cancer: a systematic review and meta-analysis 期刊论文
BMJ open, 2016, 卷号: 6, 页码: e011714
作者:  Zhang Shu[1];  Mao Xiao-Dong[2];  Wang Hai-Tao[3];  Cai Feng[4];  Xu Jing[5]
收藏  |  浏览/下载：2/0  |  提交时间：2019/04/26

©版权所有 ©2017 CSpace - Powered by CSpace